Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528015 | Clinical Therapeutics | 2018 | 10 Pages |
Abstract
Prophylaxis for digestive disorders with omeprazole and male sex may contribute to the development of kidney impairment because both result in increased serum creatinine levels. Therefore, pharmacotherapeutic follow-up of male patients diagnosed with kidney disorders should be considered to identify potential drug-drug interactions early. This follow-up can prevent worsening clinical conditions and/or contraindicate prophylactic use of omeprazole. ClinicalTrials.gov identifier: NCT02278432.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Fabiana Rossi PhD, Tales Rubens PhD, Alice Rosa Alves de Oliveira, Patricia de Carvalho PhD,